Alternatives to Rocket Pharmaceuticals

Rocket Pharmaceuticals is a Biotechnology tool: A biotechnology company developing genetic therapies for rare disorders. Here are the 53 closest alternatives, compared on pricing, features and what real users say.

Rocket Pharmaceuticals profile More Biotechnology alternatives

The 20 closest Biotechnology companies to Rocket Pharmaceuticals

BioMarin
Not rated
A global biotechnology company focused on developing and commercializing therapies for rare genetic diseases.
Visit site
Lexeo Therapeutics
3.0 out of 5 (1)
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
Visit site
Tenaya Therapeutics
Not rated
Biotechnology company developing gene therapies and regenerative medicine for heart disease.
Visit site
Alector
Not rated
Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.
Visit site
Orchard Therapeutics
Not rated
Gene therapy company developing treatments for rare inherited diseases.
Visit site
Quince Therapeutics
Not rated
A biopharmaceutical company focused on developing novel therapies.
Visit site
Mustang Bio
Not rated
Clinical-stage biopharmaceutical company developing gene therapies for rare genetic diseases.
Visit site
Bluebird Bio
Not rated
Gene therapy company developing transformative treatments for severe genetic diseases.
Visit site
Pfizer
Not rated
A global pharmaceutical and biotechnology corporation developing innovative medicines and vaccines for various therapeutic areas.
Visit site
Sylentis
Not rated
Ophthalmic pharmaceutical company developing novel treatments for ocular diseases.
Visit site
Ultragenyx
Not rated
Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.
Visit site
Sarepta
Not rated
Biopharmaceutical company focused on developing RNA-targeted therapies for rare genetic diseases.
Visit site
RD-Biotech
Not rated
RD-Biotech develops innovative solutions for drug discovery and development using advanced biotechnology.
Visit site
Denali Therapeutics
Not rated
Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.
Visit site
Vaxart
Not rated
Vaxart is a clinical-stage biotechnology company developing oral vaccines for infectious diseases.
Visit site
Spark Therapeutics
Not rated
A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
Visit site
NA
NanoZymeX
Not rated
Developing a lipid nanoparticle platform for enhanced enzyme replacement therapy.
Moderna
2.5 out of 5 (2)
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Visit site
Degron Therapeutics
Not rated
Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Visit site
Epicrispr Biotechnologies
Not rated
Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Visit site

Company	Rating	Visit
BioMarinA global biotechnology company focused on developing and commercializing therapies for rare genetic diseases.	Not rated	Visit site
Lexeo TherapeuticsClinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.	3.0 out of 5 (1)	Visit site
Tenaya TherapeuticsBiotechnology company developing gene therapies and regenerative medicine for heart disease.	Not rated	Visit site
AlectorBiotechnology company developing immuno-neurology therapies for neurodegenerative diseases.	Not rated	Visit site
Orchard TherapeuticsGene therapy company developing treatments for rare inherited diseases.	Not rated	Visit site
Quince TherapeuticsA biopharmaceutical company focused on developing novel therapies.	Not rated	Visit site
Mustang BioClinical-stage biopharmaceutical company developing gene therapies for rare genetic diseases.	Not rated	Visit site
Bluebird BioGene therapy company developing transformative treatments for severe genetic diseases.	Not rated	Visit site
PfizerA global pharmaceutical and biotechnology corporation developing innovative medicines and vaccines for various therapeutic areas.	Not rated	Visit site
SylentisOphthalmic pharmaceutical company developing novel treatments for ocular diseases.	Not rated	Visit site
UltragenyxBiopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.	Not rated	Visit site
SareptaBiopharmaceutical company focused on developing RNA-targeted therapies for rare genetic diseases.	Not rated	Visit site
RD-BiotechRD-Biotech develops innovative solutions for drug discovery and development using advanced biotechnology.	Not rated	Visit site
Denali TherapeuticsBiopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.	Not rated	Visit site
VaxartVaxart is a clinical-stage biotechnology company developing oral vaccines for infectious diseases.	Not rated	Visit site
Spark TherapeuticsA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.	Not rated	Visit site
NANanoZymeXDeveloping a lipid nanoparticle platform for enhanced enzyme replacement therapy.	Not rated
ModernaModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.	2.5 out of 5 (2)	Visit site
Degron TherapeuticsClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.	Not rated	Visit site
Epicrispr BiotechnologiesEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).	Not rated	Visit site

Showing the next 20 closest matches. See the rest on the Rocket Pharmaceuticals profile.

Sponsored rows are paid and labelled. Advertise on this page